These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1150 related items for PubMed ID: 15894683

  • 1. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E.
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [Abstract] [Full Text] [Related]

  • 2. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 3. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C.
    Cancer Epidemiol Biomarkers Prev; 2002 Apr 20; 11(4):337-41. PubMed ID: 11927493
    [Abstract] [Full Text] [Related]

  • 4. Circulating steroid hormones and the risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 20; 15(1):86-91. PubMed ID: 16434592
    [Abstract] [Full Text] [Related]

  • 5. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
    Chen C, Weiss NS, Stanczyk FZ, Lewis SK, DiTommaso D, Etzioni R, Barnett MJ, Goodman GE.
    Cancer Epidemiol Biomarkers Prev; 2003 Dec 20; 12(12):1410-6. PubMed ID: 14693730
    [Abstract] [Full Text] [Related]

  • 6. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 7. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
    Shimbo M, Suzuki H, Kamiya N, Imamoto T, Komiya A, Ueda T, Watanabe M, Shiraishi T, Ichikawa T.
    Eur Urol; 2005 Apr 18; 47(4):557-63. PubMed ID: 15774258
    [Abstract] [Full Text] [Related]

  • 8. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 9. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
    Bratt O, Borg A, Kristoffersson U, Lundgren R, Zhang QX, Olsson H.
    Br J Cancer; 1999 Oct 04; 81(4):672-6. PubMed ID: 10574254
    [Abstract] [Full Text] [Related]

  • 10. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
    Nam RK, Elhaji Y, Krahn MD, Hakimi J, Ho M, Chu W, Sweet J, Trachtenberg J, Jewett MA, Narod SA.
    J Urol; 2000 Aug 04; 164(2):567-72. PubMed ID: 10893645
    [Abstract] [Full Text] [Related]

  • 11. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
    Dalais FS, Meliala A, Wattanapenpaiboon N, Frydenberg M, Suter DA, Thomson WK, Wahlqvist ML.
    Urology; 2004 Sep 04; 64(3):510-5. PubMed ID: 15351581
    [Abstract] [Full Text] [Related]

  • 12. The androgen receptor gene GGN microsatellite and prostate cancer risk.
    Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW.
    Cancer Epidemiol Biomarkers Prev; 1998 May 04; 7(5):379-84. PubMed ID: 9610786
    [Abstract] [Full Text] [Related]

  • 13. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander EA.
    Cancer Res; 1997 Mar 15; 57(6):1194-8. PubMed ID: 9067292
    [Abstract] [Full Text] [Related]

  • 14. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ.
    Cancer Res; 2002 Feb 15; 62(4):1045-9. PubMed ID: 11861380
    [Abstract] [Full Text] [Related]

  • 15. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C, Lamharzi N, Weiss NS, Etzioni R, Dightman DA, Barnett M, DiTommaso D, Goodman G.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 15; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [Abstract] [Full Text] [Related]

  • 16. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J, Chang C.
    Cancer Res; 2000 Sep 15; 60(18):5111-6. PubMed ID: 11016637
    [Abstract] [Full Text] [Related]

  • 17. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
    Miller EA, Stanford JL, Hsu L, Noonan E, Ostrander EA.
    Prostate; 2001 Aug 01; 48(3):200-5. PubMed ID: 11494335
    [Abstract] [Full Text] [Related]

  • 18. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
    Schatzl G, Madersbacher S, Haitel A, Gsur A, Preyer M, Haidinger G, Gassner C, Ochsner M, Marberger M.
    J Urol; 2003 Apr 01; 169(4):1312-5. PubMed ID: 12629350
    [Abstract] [Full Text] [Related]

  • 19. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N, Ikonen T, Autio V, Rökman A, Matikainen MP, Tammela TL, Kallioniemi OP, Koivisto PA, Schleutker J.
    Hum Genet; 2002 Aug 01; 111(2):166-71. PubMed ID: 12189490
    [Abstract] [Full Text] [Related]

  • 20. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA, Giovannucci E.
    J Steroid Biochem Mol Biol; 2004 Nov 01; 92(4):237-53. PubMed ID: 15663987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.